| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
The Hormel Institute, University of Minnesota, Austin, Minnesota 55912
Arsenic has been used as an effective chemotherapy agent for some human cancers, such as acute promyelocytic leukemia. In this study, we found that arsenic induces activation of c-Jun NH2-terminal kinases (JNKs) at a similar dose range for induction of apoptosis in JB6 cells. In addition, we found that arsenic did not induce p53-dependent transactivation. Similarly, there was no difference in apoptosis induction between cells with p53 +/+ or p53 -/-. In contrast, arsenic-induced apoptosis was almost totally blocked by expression of a dominant-negative mutant of JNK1. These results suggest that the activation of JNKs is involved in arsenic-induced apoptosis of JB6 cells. Taken together with previous findings that p53 mutations are involved in
50% of all human cancers and nearly all chemotherapeutic agents kill cancer cells mainly by apoptotic induction, we suggest that arsenic may be a useful agent for the treatment of cancers with p53 mutation.
This article has been cited by other articles:
![]() |
E. Fox, B. I. Razzouk, B. C. Widemann, S. Xiao, M. O'Brien, W. Goodspeed, G. H. Reaman, S. M. Blaney, A. J. Murgo, F. M. Balis, et al. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma Blood, January 15, 2008; 111(2): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Song, J. Li, D. Zhang, Z.-g. Liu, J. Ye, Q. Zhan, H.-M. Shen, M. Whiteman, and C. Huang IKK{beta} programs to turn on the GADD45{alpha}-MKK4-JNK apoptotic cascade specifically via p50 NF-{kappa}B in arsenite response J. Cell Biol., November 20, 2006; 175(4): 607 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, L. Song, J. Li, K. Wu, and C. Huang Coordination of JNK1 and JNK2 Is Critical for GADD45{alpha} Induction and Its Mediated Cell Apoptosis in Arsenite Responses J. Biol. Chem., November 10, 2006; 281(45): 34113 - 34123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ding, J. Li, C. Xue, K. Wu, W. Ouyang, D. Zhang, Y. Yan, and C. Huang Cyclooxygenase-2 Induction by Arsenite Is through a Nuclear Factor of Activated T-cell-dependent Pathway and Plays an Antiapoptotic Role in Beas-2B Cells J. Biol. Chem., August 25, 2006; 281(34): 24405 - 24413. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ouyang, Q. Ma, J. Li, D. Zhang, Z.-g. Liu, A. K. Rustgi, and C. Huang Cyclin D1 Induction through I{kappa}B Kinase {beta}/Nuclear Factor-{kappa}B Pathway Is Responsible for Arsenite-Induced Increased Cell Cycle G1-S Phase Transition in Human Keratinocytes Cancer Res., October 15, 2005; 65(20): 9287 - 9293. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. McCollum, P. C. Keng, J. C. States, and M. J. McCabe Jr. Arsenite Delays Progression through Each Cell Cycle Phase and Induces Apoptosis following G2/M Arrest in U937 Myeloid Leukemia Cells J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 877 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, Y. Jing, M. Styblo, Z. Chen, and S. Waxman Glutathione-S-transferase {pi} inhibits As2O3-induced apoptosis in lymphoma cells: involvement of hydrogen peroxide catabolism Blood, February 1, 2005; 105(3): 1198 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Ivanov and T. K. Hei Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor {alpha}-mediated Pathway J. Biol. Chem., May 21, 2004; 279(21): 22747 - 22758. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Davison, K. K. Mann, S. Waxman, and W. H. Miller Jr JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells Blood, May 1, 2004; 103(9): 3496 - 3502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Y. Lau, M. Li, R. Xie, Q.-Y. He, and J.-F. Chiu Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells Carcinogenesis, January 1, 2004; 25(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. I. Dawson, Y. Ning, L. Polin, R. E. Parchment, T. Corbett, A. N. Mohamed, K.-C. Feng, L. Farhana, A. K. Rishi, et al. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog Blood, November 15, 2003; 102(10): 3743 - 3752. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Muscarella, K. A. O'Brien, A. T. Lemley, and S. E. Bloom Reversal of Bcl-2-Mediated Resistance of the EW36 Human B-Cell Lymphoma Cell Line to Arsenite- and Pesticide-Induced Apoptosis by PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor Toxicol. Sci., July 1, 2003; 74(1): 66 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Raffoux, P. Rousselot, J. Poupon, M.-T. Daniel, B. Cassinat, R. Delarue, A.-L. Taksin, D. Rea, A. Buzyn, A. Tibi, et al. Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic Leukemia J. Clin. Oncol., June 15, 2003; 21(12): 2326 - 2334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Salim, H. Wanibuchi, K. Morimura, M. Wei, M. Mitsuhashi, K. Yoshida, G. Endo, and S. Fukushima Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice Carcinogenesis, February 1, 2003; 24(2): 335 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Muscarella and S. E. Bloom Cross-linking of Surface IgM in the Burkitt's Lymphoma Cell Line ST486 Provides Protection against Arsenite- and Stress-induced Apoptosis That Is Mediated by ERK and Phosphoinositide 3-Kinase Signaling Pathways J. Biol. Chem., January 31, 2003; 278(6): 4358 - 4367. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, J. Li, Q. Zhang, and X. Huang Role of Bioavailable Iron in Coal Dust-Induced Activation of Activator Protein-1 and Nuclear Factor of Activated T Cells: Difference between Pennsylvania and Utah Coal Dusts Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 568 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, J. Li, Q. Ke, S. S. Leonard, B.-H. Jiang, X.-S. Zhong, M. Costa, V. Castranova, and X. Shi Ultraviolet-induced Phosphorylation of p70S6K at Thr389 and Thr421/Ser424 Involves Hydrogen Peroxide and Mammalian Target of Rapamycin but not Akt and Atypical Protein Kinase C Cancer Res., October 15, 2002; 62(20): 5689 - 5697. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Kim, M.-S. Kim, K.-B. Kim, K.-W. Kim, Y.-M. Hong, I.-K. Kim, H.-W. Lee, and Y.-K. Jung Sensitizing effects of cadmium on TNF-{alpha}- and TRAIL-mediated apoptosis of NIH3T3 cells with distinct expression patterns of p53 Carcinogenesis, September 1, 2002; 23(9): 1411 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Muscarella and S. E. Bloom Differential Activation of the c-Jun N-Terminal Kinase Pathway in Arsenite-Induced Apoptosis and Sensitization of Chemically Resistant Compared to Susceptible B-Lymphoma Cell Lines Toxicol. Sci., July 1, 2002; 68(1): 82 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Miller Jr. Molecular Targets of Arsenic Trioxide in Malignant Cells Oncologist, April 1, 2002; 7(90001): 14 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Dwyer Multifaceted Approach to the Treatment of Bcr-Abl-Positive Leukemias Oncologist, April 1, 2002; 7(90001): 30 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, W.-Y. Ma, A. Kaji, A. M. Bode, and Z. Dong Requirement of ATM in UVA-induced Signaling and Apoptosis J. Biol. Chem., January 25, 2002; 277(5): 3124 - 3131. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qu, C. D. Bortner, T. Sakurai, M. J. Hobson, and M. P. Waalkes Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway Carcinogenesis, January 1, 2002; 23(1): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Maeda, S. Hori, H. Nishitoh, H. Ichijo, O. Ogawa, Y. Kakehi, and A. Kakizuka Tumor Growth Inhibition by Arsenic Trioxide (As2O3) in the Orthotopic Metastasis Model of Androgen-independent Prostate Cancer Cancer Res., July 1, 2001; 61(14): 5432 - 5440. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chen, M. Nomura, Q.-B. She, W.-Y. Ma, A. M. Bode, L. Wang, R. A. Flavell, and Z. Dong Suppression of Skin Tumorigenesis in c-Jun NH2-Terminal Kinase-2-Deficient Mice Cancer Res., May 1, 2001; 61(10): 3908 - 3912. [Abstract] [Full Text] |
||||
![]() |
M. J. McCabe Jr., K. P. Singh, S. A. Reddy, B. Chelladurai, J. G. Pounds, J. J. Reiners Jr., and J. C. States Sensitivity of Myelomonocytic Leukemia Cells to Arsenite-Induced Cell Cycle Disruption, Apoptosis, and Enhanced Differentiation Is Dependent on the Inter-Relationship between Arsenic Concentration, Duration of Treatment, and Cell Cycle Phase J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 724 - 733. [Abstract] [Full Text] |
||||
![]() |
S. Mandlekar, R. Yu, T.-H. Tan, and A.-N. T. Kong Activation of Caspase-3 and c-Jun NH2-terminal Kinase-1 Signaling Pathways in Tamoxifen-induced Apoptosis of Human Breast Cancer Cells Cancer Res., November 1, 2000; 60(21): 5995 - 6000. [Abstract] [Full Text] |
||||
![]() |
K. Hossain, A. A. Akhand, M. Kato, J. Du, K. Takeda, J. Wu, K. Takeuchi, W. Liu, H. Suzuki, and I. Nakashima Arsenite Induces Apoptosis of Murine T Lymphocytes Through Membrane Raft-Linked Signaling for Activation of c-Jun Amino-Terminal Kinase J. Immunol., October 15, 2000; 165(8): 4290 - 4297. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Costantini, E. Jacotot, D. Decaudin, and G. Kroemer Mitochondrion as a Novel Target of Anticancer Chemotherapy J Natl Cancer Inst, July 5, 2000; 92(13): 1042 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, J. Li, W.-Y. Ma, and Z. Dong JNK Activation Is Required for JB6 Cell Transformation Induced by Tumor Necrosis Factor-alpha but Not by 12-O-Tetradecanoylphorbol-13-Acetate J. Biol. Chem., October 15, 1999; 274(42): 29672 - 29676. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Chen, Y. Lu, Z. Zhang, V. Vallyathan, M. Ding, V. Castranova, and X. Shi Opposite Effect of NF-kappa B and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite J. Biol. Chem., March 30, 2001; 276(14): 11414 - 11419. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |